BCRN Management Committee

Recognizing the need to more aggressively engage the research community, BCAN created a new division in our organization, BCRN–the Bladder Cancer Research Network—which is the cornerstone of our research mission.  This new division is led by a Management Committee, comprised of leading doctors and scientists representing all aspects of bladder cancer research, including urology, medical oncology, basic science, pathology, radiation oncology and population science.

 

Hikmat Al-Ahmadie, M.D.
Memorial Sloan-Kettering Cancer Center
New York, New York

 

Jessie Au, Pharm.D., PhD
Optimum Therapeutics

San Diego, CA

 

Dean F. Bajorin, M.D.
Memorial Sloan-Kettering Cancer Center
New York, New York

 

Bernard Bochner, M.D.,
Memorial Sloan-Kettering Cancer Center
New York, New York

 

Robert Dreicer M.D., MS
Cleveland Clinic
Cleveland, Ohio

 

Larry Karsh, MD, FACS, CPI
The Urology Center of Colorado
Denver, Colorado

 

David M. Latini, PhD
Baylor College of Medicine
Houston, Texas

 

Cheryl Lee, M.D., FACS*
University of Michigan
Ann Arbor, Michigan

 

Seth Lerner, M.D., FACS
Baylor College of Medicine
Houston, Texas

 

David J. McConkey, M.D., PhD.
M.D. Anderson Cancer Center
Houston, Texas

 

William U. Shipley, M.D., FACR
Harvard Medical School and Massachusetts General Hospital
Cambridge and Boston, Massachusetts

 

Walter Stadler, M.D., FACP
University of Chicago
Chicago, Illinois

 

Gary D. Steinberg, M.D., FACS (Ex-offico)
University of Chicago
Chicago, Illinois

 

Diane Zipursky Quale

BCAN President

Bethesda, Maryland

 

Colin P.N. Dinney, M.D. (Ex-officio)
MD Anderson Cancer Center
Houston, Texas

 

Yair Lotan, M.D. (Ex-officio)
UT Southwestern Medical Center
Dallas, Texas

 

Matthew I. Milowsky, M.D. (Ex-officio)
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina

Share this page:FacebookTwitterGoogle+tumblrLinkedInEmail
GO TO TOP ^
This website is supported by a generous grant from Photocure
SITE DESIGN: GALANTI DESIGN